A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)

NCT01023724 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Post Operative Anterior Chamber Inflammation (Flare)

Interventions

DRUG: Ketorolac Tromethamine 0.45%
DRUG: Bromfenac 0.09%

Sponsor

Bucci Laser Vision Institute

Collaborators

[object Object]